Literature DB >> 15845904

Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1.

Jeffrey F W Keuren1, Simone J H Wielders, Hans Ulrichts, Tilman Hackeng, Johan W M Heemskerk, Hans Deckmyn, Edouard M Bevers, Theo Lindhout.   

Abstract

OBJECTIVE: In the blood coagulation process, the rate of thrombin formation is critically dependent on phosphatidylserine (PtdSer) at the surface of activated platelets. Thrombin synergistically enhances the collagen-induced platelet procoagulant response. The objective of this study is to elucidate the mechanism of this synergistic action with a focus on the intracellular Ca2+ concentration ([Ca2+]i) and the various platelet receptors for thrombin. METHODS AND
RESULTS: We demonstrate that procoagulant activity is related to a sustained increased [Ca2+]i, which in turn depends on extracellular Ca2+ influx. Increased PtdSer exposure coincides with increased [Ca2+]i and was observed in a subpopulation (approximately 14%) of the platelets after stimulation with thrombin plus collagen. 2D2-Fab fragments against the thrombin binding site on GPIbalpha made clear that this receptor did not signal for platelet procoagulant activity. Inhibition of protease-activated receptor 1 (PAR-1) and PAR-4 by selective intracellular inhibitors and selective desensitization of these receptors revealed that PAR-1, but not PAR-4, activation is a prerequisite for both sustained elevations in [Ca2+]i and procoagulant activity induced by collagen plus thrombin.
CONCLUSIONS: The interaction of thrombin with PAR-1 mediates a synergistic effect on collagen-induced procoagulant activity by inducing a sustained elevation in [Ca2+]i in a subpopulation of platelets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845904     DOI: 10.1161/01.ATV.0000167526.31611.f6

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

Review 1.  Markers of platelet apoptosis: methodology and applications.

Authors:  Armen V Gyulkhandanyan; Asuman Mutlu; John Freedman; Valery Leytin
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow.

Authors:  Judith M E M Cosemans; Saskia E M Schols; Lucia Stefanini; Susanne de Witt; Marion A H Feijge; Karly Hamulyák; Hans Deckmyn; Wolfgang Bergmeier; Johan W M Heemskerk
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

3.  Lack of early augmentation of platelet reactivity after coronary intervention in patients treated with bivalirudin.

Authors:  David J Schneider; Burton E Sobel
Journal:  J Thromb Thrombolysis       Date:  2008-07-08       Impact factor: 2.300

Review 4.  Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development.

Authors:  Katie O'Callaghan; Athan Kuliopulos; Lidija Covic
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 5.  Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

Authors:  Sarah L Tressel; Georgios Koukos; Boris Tchernychev; Suzanne L Jacques; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2011

6.  Differential involvement of thrombin receptors in Ca2+ release from two different intracellular stores in human platelets.

Authors:  Isaac Jardin; Nidhal Ben Amor; Ahgleb Bartegi; José A Pariente; Ginés M Salido; Juan A Rosado
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention.

Authors:  Carey Kimmelstiel; Ping Zhang; Navin K Kapur; Andrew Weintraub; Barath Krishnamurthy; Vilma Castaneda; Lidija Covic; Athan Kuliopulos
Journal:  Circ Cardiovasc Interv       Date:  2011-03-01       Impact factor: 6.546

Review 8.  Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.

Authors:  Sergio Leonardi; Pierluigi Tricoci; Richard C Becker
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

Review 9.  Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase?

Authors:  Karl Kunzelmann; Bernd Nilius; Grzegorz Owsianik; Rainer Schreiber; Jiraporn Ousingsawat; Lalida Sirianant; Podchanart Wanitchakool; Edouard M Bevers; Johan W M Heemskerk
Journal:  Pflugers Arch       Date:  2013-06-08       Impact factor: 3.657

10.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.